HOME >> MEDICINE >> NEWS
Drip And Ship: Start Drug Early, Especially If Plan To Transfer Heart Patient To Larger Hospital

DALLAS -- For smaller community hospitals that routinely transfer their sicker heart attack patients to larger tertiary care facilities for advanced treatment, the immediate use of a new anti-platelet drug improves the odds that the patient will not die or suffer a second heart attack within 30 days.

Based on the results of their so-called "Drip and Ship" study, researchers from the Duke Clinical Research Institute (DCRI), further recommend that these smaller hospitals immediately begin infusion of the drug eptifibatide (trade name Integrilin) in their suspected heart attack patients with unstable angina, regardless of whether the hospital transfers the sicker patients to larger facilities.

The international 11,000-patient PURSUIT trial, the results of which were published this summer in the New England Journal of Medicine, demonstrated that eptifibatide significantly reduced the 30-day incidence of death or heart attack in heart patients who were admitted to the hospital with unstable coronary syndromes.

Since the majority of these patients are first seen in smaller community hospitals, the DCRI researchers wanted to know if it mattered when the drug was administered -- before or after transfer.

"For these smaller hospitals, the message is clear -- begin the drug immediately," said study author Dr. Adam Greenbaum. "Furthermore, the decision of whether or not to transfer should be based on clinical considerations. In some cases, it appears that starting the drug at the smaller hospital may even alleviate the need to transfer altogether."

Greenbaum, a cardiology fellow at the DCRI, prepared the results of his study for presentation Tuesday (Nov. 10) at the 71st scientific sessions of the American Heart Association meeting.

Eptifibatide, a class of drug known as platelet glycoprotein IIb/IIIa inhibitors, interrupts the cascade of events that causes platelets circulating in the blood t
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
10-Nov-1998


Page: 1 2

Related medicine news :

1. Starting dose of Lexapro as effective as optimally dosed Zoloft in the treatment of depression
2. Starting beta-blocker before discharge in patients hospitalized for heart failure increases usage
3. Smart Start achieving goals, UNC center report indicates
4. High-achieving children off to a good Head Start academically and socially, but study shows some are not turned on by school
5. Intensive Program Can Help Premature Babies Learn At the Start
6. Stopping High Blood Pressure Drugs May Start A Stroke
7. Positive Results Of Pivotal Phase III Trial With ENBREL In Patients With Early, Active Rheumatoid Arthritis
8. Radon, Especially In Combination With Smoking, Contributes To Lung Cancer Deaths
9. Study: Transferred patients hurt big hospitals rankings
10. The European Society of Cardiology launches Women at Heart
11. Heart surgeons publish death rates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... ... country with the Davidson Fellows Scholarship on September 27 at a reception in ... Science, Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... positively linked to the Certified Emergency Nurse (CEN®) certification according to ... (BCEN). The value of certification study, conducted by the Human Resources Research Organization ...
(Date:9/18/2017)... ... September 19, 2017 , ... ... ingredient market , expected to grow at the fastest CAGR of 9.1% over ... ‘Global Food Protein Trends & Growth Opportunities in Asia’ – highlighting alternative proteins, ...
(Date:9/18/2017)... , ... September 18, 2017 , ... ... recently expanded the finance role on the executive team adding a Chief Financial ... to an independent company. This expansion will support the strategic growth strategy Aegis ...
(Date:9/18/2017)... ... September 18, 2017 , ... While Floridians confront the ... jersey based company, has launched an aid effort focused on the elderly population that ... state over two days and left thousands homeless and displaced. , “The elderly are ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... --  OrthoAtlanta has been named the official orthopedic and ... for the 2018 College Football Playoff (CFP) National Championship to ... in Atlanta, Georgia . OrthoAtlanta is proud ... participating in many activities leading up to, and including the ... ...
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical Supplies, ... supplier of medical equipment, supplies, drugs, vaccines, and specialty ... entered into an agreement to acquire Vantage Medical Supplies, ... in Holtsville, New York . ... supplying new and emerging medical practices, will operate under ...
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir (formerly ... Spirometer, announced today a partnership with Novartis Pharma AG to ... NuvoAir,s position as the leading mobile spirometry platform and Novartis, ... ... ...
Breaking Medicine Technology:
Cached News: